Apac
  • Home
  • CXO Insights
  • CIO Views
  • News
  • Conferences
  • Newsletter
  • Whitepapers
  • About us
Apac
  • Admired Tech

    Agile

    AI Healthcare

    Artificial Intelligence

    Augmented Reality

    Aviation

    Big Data

    Blockchain

    Cloud

    Cryptocurrency

    Cyber Security

    Digital Transformation

    Drone

    HPC

    Infrared

    Internet of Things

    Networking

    PropTech

    Remote Work

    Scheduling Software

    Simulation

    Startup

    Storage

    Wireless

  • Banking

    E-Commerce

    Education

    FinTech

    Food and Beverages

    Healthcare

    Insurance

    Legal

    Manufacturing

    Pharma and Life Science

    Retail

    Travel and Hospitality

  • CISCO

    Microsoft

    Oracle

    Salesforce

    SAP

    ServiceNow

  • Business Intelligence

    CEM

    Cloud-based Planning

    Cognitive

    Compliance

    Contact Center

    Contact Tracing

    Contactless Payments

    Corporate Finance

    CRM

    Custom Software Development

    Data Center

    Enterprise Architecture

    Enterprise Communications

    Enterprise Contract Management

    Field Service

    HR Technology

    IT Service Management

    Managed Services

    Procurement

    Product Management

    RegTech

    Revenue Management

Menu
    • CISCO
    • Collaboration
    • Compliance
    • Contact Center
    • Healthcare
    • IT Service Management
    • Microsoft
    • Retail
    • MORE
    #

    Apac CIO Outlook Weekly Brief

    ×

    Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Apac CIO Outlook

    Subscribe

    loading

    THANK YOU FOR SUBSCRIBING

    • Home
    • News
    • Healthcare
    Editor's Pick (1 - 4 of 8)
    left
    Technology’s Role in The Care and Quality of Life for The Aged

    Jose A Perez, Chief Information Officer, Hammondcare

    Digital Transformation - The Right Way

    Amit Goel, CIO, Metropolis Healthcare

    The (E-) Doctor Is In: What Trends to Spot in Healthcare Technology Today

    Dickon Smart-Gill, CIO, Bumrungrad International Hospital

    Analytics and AI in Healthcare

    Steven Parrish, CIO, Taranaki District Health Board

    Document Management in the Cloud

    Alex Choy, EVP R&D CIO, Change Healthcare

    China Embracing Connected Health

    Geoff Feakes, Group CIO, Tunstall Healthcare

    How Healthy is Your IT?

    John Sutherland-CIO-Ramsay Health Care

    Enterprise Architecture - An Extremely Valuable Discipline for Great Businesses

    Ken Spangler, SVP & CIO FedEx Ground and FedEx Freight, FedEx Services IT

    right

    Hummingbird Bioscience Closes Series B Extension Round after Collecting US$25M

    By Apac CIO Outlook | Tuesday, May 12, 2020
    Tweet

    Hummingbird Bioscience, raised US$25 million from series B extension funding 

    Fremont, CA: Hummingbird Bioscience, an innovative biotherapeutics company that aims to discover and conjure the development of breakthrough therapies, has successfully closed an extended Series B investment round after raising US$25 million. The total capital raised by the firm through financing activities and strategic partnerships will account to more than US$65 million to date. 

    The latest Series B extension round was led by the new investor SK Holdings, along with the participation from existing shareholders, including Heritas Capital and SEEDS Capital, the investment wing of Enterprise Singapore.

    Top 10 Healthcare Technology Solution Companies - 2020The Series B round was extended to US$25 million due to the significant over-subscription, along with the addition of select quality and value-add investors. Hummingbird will use the newly collected funds to accelerate the development of new candidates into clinical trials, strengthen it is scientific and research and development capabilities. 

    “We are delighted to have SK Holdings join our investor base. Hummingbird is building a strong portfolio of promising new therapies that we believe can deliver significant benefits for patients across a broad spectrum of diseases. These new funds give us further resources to develop our early-stage pipeline, and support the clinical development of our lead programs,” said Dr. Piers Ingram, Chief Executive Officer, and co-founder, Hummingbird Bioscience.

    “Heritas Capital is pleased to continue our backing of the Hummingbird team since leading its Series A extended round,” commented Chik Wai Chiew, Executive Director and Chief Executive Officer, Heritas Capital Management. “Even as the COVID-19 pandemic has resulted in a slow-down in investing, we are mindful that backing leading innovative biotech companies, especially players such as Hummingbird, to develop cures for addressing patients’ needs remains our priority.”

    In the first few days of the year, Hummingbird obtained positive data to the lead candidate, HMBD-001, a first-in-class HER3 antibody, and manufacturing of HMBD-002, another first-in-class VISTA antibody. The regulatory submissions to initiate the Phase I research on the two candidates are expected to happen in the second half of 2020.

    Weekly Brief

    loading
    ON THE DECK

    Content Management System 2020

    Top Vendors

    Contactless Payments 2020

    Top Vendors

    Admired Tech 2020

    Top Vendors

    Previous Next

    I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

    Read Also

    How Credible is Cloud Storage Security?

    How Credible is Cloud Storage Security?

    How Internet of Medical Things Changing the Facets of Healthcare

    How Internet of Medical Things Changing the Facets of Healthcare

    IoT and the Challenges it Faces

    IoT and the Challenges it Faces

    Key Advantages of Cloud Computing

    Key Advantages of Cloud Computing

    Five Best Practices of Implementing ITSM

    Five Best Practices of Implementing ITSM

    Three Significant Benefits of Blockchain in Healthcare

    Three Significant Benefits of Blockchain in Healthcare

    Loading...

    Copyright © 2021 APAC CIOoutlook. All rights reserved. Registration on or use of this site constitutes acceptance of our Terms of Use and Privacy Policy  |  Sitemap |  Subscribe

    follow on linkedinfollow on twitter follow on rss
    This content is copyright protected

    However, if you would like to share the information in this article, you may use the link below:

    https://www.apacciooutlook.com/news/hummingbird-bioscience-closes-series-b-extension-round-after-collecting-us25m-nwid-7460.html